Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.02
HCA's Cash to Debt is ranked lower than
92% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 0.30 vs. HCA: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
HCA' s 10-Year Cash to Debt Range
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity to Asset -0.23
HCA's Equity to Asset is ranked lower than
95% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HCA: -0.23 )
Ranked among companies with meaningful Equity to Asset only.
HCA' s 10-Year Equity to Asset Range
Min: -0.5  Med: 0.23 Max: 0.42
Current: -0.23
-0.5
0.42
Interest Coverage 3.19
HCA's Interest Coverage is ranked lower than
70% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 6.48 vs. HCA: 3.19 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s 10-Year Interest Coverage Range
Min: 1.42  Med: 3.12 Max: 6.33
Current: 3.19
1.42
6.33
F-Score: 8
Z-Score: 2.15
M-Score: -2.78
WACC vs ROIC
6.59%
18.72%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 15.14
HCA's Operating margin (%) is ranked higher than
75% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 7.11 vs. HCA: 15.14 )
Ranked among companies with meaningful Operating margin (%) only.
HCA' s 10-Year Operating margin (%) Range
Min: 5.48  Med: 11.95 Max: 15.84
Current: 15.14
5.48
15.84
Net-margin (%) 5.58
HCA's Net-margin (%) is ranked higher than
60% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 3.47 vs. HCA: 5.58 )
Ranked among companies with meaningful Net-margin (%) only.
HCA' s 10-Year Net-margin (%) Range
Min: -1.62  Med: 4.39 Max: 7.58
Current: 5.58
-1.62
7.58
ROA (%) 6.96
HCA's ROA (%) is ranked higher than
72% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.60 vs. HCA: 6.96 )
Ranked among companies with meaningful ROA (%) only.
HCA' s 10-Year ROA (%) Range
Min: -1.41  Med: 5.02 Max: 9.71
Current: 6.96
-1.41
9.71
ROC (Joel Greenblatt) (%) 32.19
HCA's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. HCA: 32.19 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HCA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.48  Med: 27.59 Max: 51.73
Current: 32.19
7.48
51.73
Revenue Growth (3Y)(%) 7.70
HCA's Revenue Growth (3Y)(%) is ranked lower than
52% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. HCA: 7.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HCA' s 10-Year Revenue Growth (3Y)(%) Range
Min: -9.7  Med: 4.80 Max: 13.4
Current: 7.7
-9.7
13.4
EBITDA Growth (3Y)(%) 3.20
HCA's EBITDA Growth (3Y)(%) is ranked lower than
72% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. HCA: 3.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HCA' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.4  Med: 3.70 Max: 24.4
Current: 3.2
-9.4
24.4
EPS Growth (3Y)(%) -5.80
HCA's EPS Growth (3Y)(%) is ranked lower than
74% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. HCA: -5.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HCA' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -5.80 Max: 88.4
Current: -5.8
0
88.4
» HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

HCA Guru Trades in Q3 2014

Ken Heebner 1,795,000 sh (New)
Andreas Halvorsen 1,794,780 sh (New)
Steven Cohen 102,600 sh (New)
Paul Tudor Jones 262,488 sh (+1512.73%)
John Paulson 6,069,600 sh (+78.38%)
Louis Moore Bacon 147,531 sh (+56.38%)
First Eagle Investment 3,171,122 sh (+6.99%)
Pioneer Investments 549,841 sh (unchged)
David Tepper 5,326,882 sh (unchged)
Mario Gabelli 35,000 sh (unchged)
Stanley Druckenmiller Sold Out
Jim Simons Sold Out
Leon Cooperman 2,441,700 sh (-4.05%)
Vanguard Health Care Fund 5,665,000 sh (-16.03%)
Larry Robbins 9,610,559 sh (-18.98%)
Lee Ainslie 4,157,133 sh (-30.60%)
Caxton Associates 25,000 sh (-75.00%)
Joel Greenblatt 3,699 sh (-85.33%)
» More
Q4 2014

HCA Guru Trades in Q4 2014

Jim Simons 382,900 sh (New)
Steve Mandel 5,836,872 sh (New)
Andreas Halvorsen 3,870,654 sh (+115.66%)
Steven Cohen 118,900 sh (+15.89%)
Vanguard Health Care Fund 6,143,500 sh (+8.45%)
Pioneer Investments 551,937 sh (+0.38%)
Joel Greenblatt Sold Out
Ken Heebner Sold Out
Caxton Associates Sold Out
David Tepper 5,010,582 sh (-5.94%)
Lee Ainslie 3,285,443 sh (-20.97%)
John Paulson 4,711,900 sh (-22.37%)
Larry Robbins 6,178,678 sh (-35.71%)
Mario Gabelli 20,000 sh (-42.86%)
Paul Tudor Jones 147,976 sh (-43.63%)
First Eagle Investment 1,415,378 sh (-55.37%)
Leon Cooperman 1,088,500 sh (-55.42%)
Louis Moore Bacon 27,556 sh (-81.32%)
» More
Q1 2015

HCA Guru Trades in Q1 2015

Robert Olstein 62,000 sh (New)
David Dreman 28,963 sh (New)
Caxton Associates 15,000 sh (New)
Mario Gabelli 25,000 sh (+25.00%)
Vanguard Health Care Fund 7,075,900 sh (+15.18%)
Pioneer Investments 619,170 sh (+12.18%)
Steve Mandel 5,836,872 sh (unchged)
John Paulson 4,711,900 sh (unchged)
Jim Simons Sold Out
First Eagle Investment Sold Out
Leon Cooperman Sold Out
Steven Cohen Sold Out
David Tepper 4,906,582 sh (-2.08%)
Larry Robbins 5,178,678 sh (-16.18%)
Lee Ainslie 874,177 sh (-73.39%)
Andreas Halvorsen 1,016,617 sh (-73.74%)
Louis Moore Bacon 5,870 sh (-78.70%)
Paul Tudor Jones 10,532 sh (-92.88%)
» More
Q2 2015

HCA Guru Trades in Q2 2015

John Burbank 61,554 sh (New)
Steven Cohen 7,100 sh (New)
Jim Simons 64,100 sh (New)
Joel Greenblatt 25,396 sh (New)
Louis Moore Bacon 123,119 sh (+1997.43%)
Paul Tudor Jones 34,599 sh (+228.51%)
Vanguard Health Care Fund 7,647,300 sh (+8.08%)
Mario Gabelli 27,000 sh (+8.00%)
John Paulson 4,711,900 sh (unchged)
Larry Robbins 5,178,578 sh (unchged)
Andreas Halvorsen Sold Out
Lee Ainslie Sold Out
Caxton Associates Sold Out
David Dreman 28,337 sh (-2.16%)
Steve Mandel 5,007,242 sh (-14.21%)
David Tepper 4,184,525 sh (-14.72%)
Robert Olstein 49,000 sh (-20.97%)
Pioneer Investments 165,368 sh (-73.29%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about HCA Holdings Inc

Steve Mandel Buys Visa, DaVita Healthcare In Q4
Steve Mandel (Trades, Portfolio) founded hedge fund Lone Pine Capital in 1997, which employs a bottom-up stock picking strategy. Using both value and growth strategies, Mandel tends not to hold stocks for very long. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 17.97
HCA's P/E(ttm) is ranked higher than
74% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. HCA: 17.97 )
Ranked among companies with meaningful P/E(ttm) only.
HCA' s 10-Year P/E(ttm) Range
Min: 3.87  Med: 13.80 Max: 19.7
Current: 17.97
3.87
19.7
Forward P/E 15.22
HCA's Forward P/E is ranked higher than
78% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 19.76 vs. HCA: 15.22 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 17.60
HCA's PE(NRI) is ranked higher than
77% of the 149 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. HCA: 17.60 )
Ranked among companies with meaningful PE(NRI) only.
HCA' s 10-Year PE(NRI) Range
Min: 3.87  Med: 13.79 Max: 19.72
Current: 17.6
3.87
19.72
P/S 1.01
HCA's P/S is ranked higher than
68% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. HCA: 1.01 )
Ranked among companies with meaningful P/S only.
HCA' s 10-Year P/S Range
Min: 0.32  Med: 0.54 Max: 1.06
Current: 1.01
0.32
1.06
PFCF 15.11
HCA's PFCF is ranked higher than
72% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 24.04 vs. HCA: 15.11 )
Ranked among companies with meaningful PFCF only.
HCA' s 10-Year PFCF Range
Min: 4.08  Med: 9.12 Max: 17.2
Current: 15.11
4.08
17.2
POCF 7.97
HCA's POCF is ranked higher than
82% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 15.33 vs. HCA: 7.97 )
Ranked among companies with meaningful POCF only.
HCA' s 10-Year POCF Range
Min: 2.57  Med: 4.89 Max: 8.48
Current: 7.97
2.57
8.48
EV-to-EBIT 11.85
HCA's EV-to-EBIT is ranked higher than
82% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. HCA: 11.85 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s 10-Year EV-to-EBIT Range
Min: 8.1  Med: 11.00 Max: 13.3
Current: 11.85
8.1
13.3
PEG 4.63
HCA's PEG is ranked lower than
74% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 2.77 vs. HCA: 4.63 )
Ranked among companies with meaningful PEG only.
HCA' s 10-Year PEG Range
Min: 0.48  Med: 1.11 Max: 16.68
Current: 4.63
0.48
16.68
Shiller P/E 29.90
HCA's Shiller P/E is ranked higher than
53% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.72 vs. HCA: 29.90 )
Ranked among companies with meaningful Shiller P/E only.
HCA' s 10-Year Shiller P/E Range
Min: 5.39  Med: 9.87 Max: 31.71
Current: 29.9
5.39
31.71
Current Ratio 1.47
HCA's Current Ratio is ranked higher than
56% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. HCA: 1.47 )
Ranked among companies with meaningful Current Ratio only.
HCA' s 10-Year Current Ratio Range
Min: 0.81  Med: 1.51 Max: 1.9
Current: 1.47
0.81
1.9
Quick Ratio 1.26
HCA's Quick Ratio is ranked higher than
53% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. HCA: 1.26 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s 10-Year Quick Ratio Range
Min: 0.71  Med: 1.34 Max: 1.68
Current: 1.26
0.71
1.68
Days Inventory 71.62
HCA's Days Inventory is ranked lower than
88% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 17.13 vs. HCA: 71.62 )
Ranked among companies with meaningful Days Inventory only.
HCA' s 10-Year Days Inventory Range
Min: 20.43  Med: 57.48 Max: 71.64
Current: 71.62
20.43
71.64
Days Sales Outstanding 55.13
HCA's Days Sales Outstanding is ranked lower than
65% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 46.03 vs. HCA: 55.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s 10-Year Days Sales Outstanding Range
Min: 44.84  Med: 51.58 Max: 56.3
Current: 55.13
44.84
56.3

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 3.79
HCA's Price/Projected FCF is ranked lower than
82% of the 100 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. HCA: 3.79 )
Ranked among companies with meaningful Price/Projected FCF only.
HCA' s 10-Year Price/Projected FCF Range
Min: 3.41  Med: 4.43 Max: 17.96
Current: 3.79
3.41
17.96
Price/DCF (Earnings Based) 2.25
HCA's Price/DCF (Earnings Based) is ranked lower than
83% of the 23 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. HCA: 2.25 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.88
HCA's Price/Median PS Value is ranked lower than
84% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.11 vs. HCA: 1.88 )
Ranked among companies with meaningful Price/Median PS Value only.
HCA' s 10-Year Price/Median PS Value Range
Min: 0.66  Med: 1.04 Max: 1.92
Current: 1.88
0.66
1.92
Price/Peter Lynch Fair Value 3.58
HCA's Price/Peter Lynch Fair Value is ranked lower than
66% of the 53 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. HCA: 3.58 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HCA' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.57  Med: 0.94 Max: 3.66
Current: 3.58
0.57
3.66
Earnings Yield (Greenblatt) (%) 8.40
HCA's Earnings Yield (Greenblatt) (%) is ranked higher than
85% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. HCA: 8.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HCA' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 7.5  Med: 9.10 Max: 12.3
Current: 8.4
7.5
12.3
Forward Rate of Return (Yacktman) (%) 10.47
HCA's Forward Rate of Return (Yacktman) (%) is ranked lower than
52% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 11.17 vs. HCA: 10.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HCA' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -9.8  Med: 7.10 Max: 41.9
Current: 10.47
-9.8
41.9

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 40,301 42,542 45,116
EPS($) 5.26 5.84 6.77
EPS without NRI($) 5.26 5.84 6.77

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 166 hospitals, comprised of 162 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operated 113 freestanding surgery centers. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.
» More Articles for HCA

Headlines

Articles On GuruFocus.com
Obamacare Makes HCA a Buy Aug 24 2015 
Weekly CEO Sells Highlight: Netlist Inc, Amphastar Pharmaceuticals Inc, G-III Apparel Group Ltd, and Jun 14 2015 
The Olstein All Cap Value Fund’s Q1 2015 Letter to Shareholders May 28 2015 
Weekly Insider Sells Highlight: VRX, HCA, GPRO, GD May 11 2015 
prg May 09 2015 
Weekly Insider Sells Highlight: TWTR, HCA, BBBY, KMX Apr 20 2015 
Other Highly Concentrated Fund´s Portfolio Mar 31 2015 
Steve Mandel Buys Visa, DaVita Healthcare In Q4 Feb 19 2015 
David Tepper's Top 4 Holdings: GM, C, PCLN and HCA Nov 25 2014 
These 10 Stocks Are Likely To Outperform Jun 17 2014 

More From Other Websites
U.S.-Focused Growth Stocks Could Be the Next Leaders Aug 29 2015
Volatility value picks Aug 28 2015
Widening High-Yield Bond Spreads: Opportunity or Threat? Aug 27 2015
Hedge Funds Were Opening Positions in These 5 Healthcare Stocks Aug 25 2015
Healthcare's Coming Black Swan Events Aug 23 2015
HCA's top doc: Big data is already reshaping the country's biggest hospital company Aug 20 2015
HealthCor Management’s Core Health Picks For Q3 Aug 19 2015
What HCA’s big bet on freestanding ERs means for Tampa Bay development Aug 19 2015
HCA HOLDINGS, INC. Financials Aug 13 2015
HCA proposes 100-bed hospital in Miami-Dade County Aug 12 2015
10-Q for HCA Holdings, Inc. Aug 07 2015
Top trades for the 2nd half: HCA, TLT & SHAK Aug 07 2015
HCA receives vote of confidence Aug 06 2015
Edited Transcript of HCA earnings conference call or presentation 5-Aug-15 2:00pm GMT Aug 05 2015
Hospitals Fall As HCA Sees Uninsured Patients Spike Despite ObamaCare Aug 05 2015
3 trades you may be missing Aug 05 2015
HCA Holdings revenue rises on increased admissions, visits Aug 05 2015
Hospital Operator HCA Reports Higher Profits, Admissions Aug 05 2015
HCA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 05 2015
HCA beats Street 2Q forecasts Aug 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK